Bunge Q3 FY2026: adjusted EPS $2.56 edges consensus, outlook held
Bunge beat the adjusted EPS consensus by about $0.05 and kept its full-year range intact, but the headline number came with a heavy working-capital drag. Adjusted EPS of $2.56 compares with $2.509 expected, and net sales rose 7.4% to $23.80 billion. Read the beat alongside $2.30 billion of operating cash used in nine months, because inventory, not profit, is where the cash went.
1 · Expected vs. Actual
Free preview belowGAAP diluted EPS was $1.64 against $0.86 a year earlier, and adjusted EPS was $2.56 against $2.27. The adjusted figure beat the $2.509 consensus by roughly $0.05, or about 2.0%. The gap between the two EPS lines is $0.64 per share of certain charges plus $0.28 of mark-to-market timing differences, including an $82 million loss on the announced sale of two Brazilian sugarcane mills.
Net sales were $23.80 billion, up 7.4% from $22.16 billion a year earlier. Soybean Processing and Refining supplied $11.44 billion of that and Grain Merchandising and Milling $6.76 billion. Cost of goods sold of $22.47 billion left gross profit of $1.33 billion, so the extra sales volume arrived with a thin margin attached.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-11-02
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.